In vivo imaging of endogenous pancreatic beta cell mass in healthy and type 1 diabetic subjects usin...
In vivo imaging of endogenous pancreatic beta cell mass in healthy and type 1 diabetic subjects using [18F]FP-(+)-DTBZ and PET
About this item
Full title
Author / Creator
Journal title
Language
English
Formats
More information
Scope and Contents
Contents
The ability to non-invasively measure endogenous pancreatic β-cell mass (BCM) would accelerate research on the pathophysiology of diabetes and revolutionize the preclinical development of new treatments, the clinical assessment of therapeutic efficacy, and the early diagnosis and subsequent monitoring of disease progression. The vesicular monoamine...
Alternative Titles
Full title
In vivo imaging of endogenous pancreatic beta cell mass in healthy and type 1 diabetic subjects using [18F]FP-(+)-DTBZ and PET
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3737743
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3737743
Other Identifiers
ISSN
0161-5505
E-ISSN
1535-5667
DOI
10.2967/jnumed.111.100545
